Wird geladen...
Experimental Serotonergic Agents for the Treatment of Schizophrenia
Schizophrenia remains one of the most chronic and highly disabling mental disorder. To date, the pathomechanism of schizophrenia is not fully understood and current treatments are characterized by some limitations. First- and second-generation antipsychotics have shown clinical efficacy in treating...
Gespeichert in:
| Veröffentlicht in: | J Exp Pharmacol |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7872893/ https://ncbi.nlm.nih.gov/pubmed/33574716 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JEP.S259317 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|